5 year beta glucan follow up

[Guest guest]

cures for cancer

From: dnkostyahotmail

Date sent: Sat, 16 Jun 2001 17:16:19 -0000

Send reply to: cures for cancer

Subject: Re: Hoxey -- Was he able to heal himself ?

> What to use instead? Beta glucan?

> Transfer factor? Enzymes? I'm not arguing – they

> might work. But can you provide data from clinical trials demonstrating

> that, for example, 95/85/75% of patients who took them are well and alive

> at least 5 years later? I don't think so. I'm just

> stating the fact – no such data exists.

Hi Again,

Do you realise that by deterring people from alternative therapies you may reducing their chance of survival at 5 years?

PSK is a beta glucan product.

QUOTE from a beta glucan (PSK) cinical trial.

" the median follow-up time for this study was four years (range, three to five years). The disease-free survival curve and the survival curve of the PSK group were better than those of the control group, and differences between the two

groups were statistically significant"

Will you give me 15 million $ to fund the trials that you request? Will any one pay that money?

The 5 year follow up below was better when glucan was used against cancer.

..

H Koike A Saji S Ogawa N Sakamoto J of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with

PSK for Gastric Cancer.

: Lancet (1994 May 7) 343(8906):1122-6

We have

assessed the efficacy of protein-bound polysaccharide (PSK) in

addition to standard chemotherapy in patients who had undergone

curative gastrectomy at 46 institutions in central Japan. 262

patients were randomly assigned standard treatment alone or with PSK.

The minimum follow-up time was 5 years (range 5-7 years). PSK

improved both the 5-year disease-free rate (70.7 vs 59.4% in standard

treatment group, p = 0.047) and 5-year survival (73.0 vs 60.0%, p =

0.044). Addition of PSK to adjuvant chemotherapy with mitomycin and fluorouracil is beneficial as treatment after curative gastrectomy.

Yokoyama Gastrointestinal Hospital

Japan.

90329611

M Hayashi Y Ishimitsu T Fujimura T Iwasaki K Katano M

Yamamoto H Kimura Y Takesue M Kondo M et al

PSK is a beta glucan product.

Prolongation of disease-free period gained by oral

polysaccharide K (PSK) administration after curative surgical

operation of colorectal cancer.

Cancer Immunol Immunother (1990) 31(5):261-8

To examine the clinical efficacy and the mechanism of action of

polysaccharide K (PSK), a protein-bound polysaccharide extracted from

a Basidiomycetes fungus, a randomized double-blind trial was

performed by administering PSK to 56 patients and a placebo to

another group of 55 patients after surgical operations on their

colorectal cancers. The rate of patients in remission (or disease-

free) was significantly higher in the PSK group than in the placebo

group; the difference between both groups was statistically

significant at P less than 0.05 by the log-rank test. The survival

rate of patients was also significantly (P less than 0.05) higher in

the PSK group than in the control group. The most significant

laboratory finding was that polymorphonuclear leukocytes from PSK-

treated patients showed remarkable enhancement in their activities,

such as random and/or chemotactic locomotion, and phagocytic

activity, when compared with those in the control group. The

beneficial effects were probably due to the activation of leukocyte

functions as one of the many biological-response-modifying

(activities induced by PSK).

address:

First Department of Surgery

Kyushu University School of Medicine

Fukuoka

Japan.

94091790

K Mitsuhashi N Saito Y Takahashi M Katano S Shiojima K

Furuta M Niibe H of krestin (PSK) as adjuvant treatment on the prognosis after

radical radiotherapy in patients with non-small cell lung cancer.

: Anticancer Res (1993 Sep-Oct) 13(5C):1815-20

1976 to 1985, 185 patients with non-small cell lung cancer at

stages I-III were treated. In particular, as a result of administering PSK

as adjuvant treatment to patients with epidermoid carcinoma of the

lung showing satisfactory tumour shrinkage after radiotherapy, the

five year survival rate of the patients with stages I or II disease,

as well as stage III was 39% and 22% respectively, compared with the

non-administered group's 16% and 5%. These differences are

statistically significant.

92136955

T Tsuchiya S Iijima N Aso K Suzuki K Nishiyama K Amano T

Takahashi T Murayama N Oka H et al , controlled study on adjuvant immunochemotherapy with PSK

in curatively resected colorectal cancer. The ative Study Group

of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and

Rectum (Kanagawa).

: Dis Colon Rectum (1992 Feb) 35(2):123-30

A randomized, controlled trial of adjuvant immunochemotherapy with

PSK (Kureha Chemical Industry Co., Tokyo, Japan) in curatively

resected colorectal cancer was studied in 35 institutions in the

Kanagawa prefecture. From March 1985 to February 1987, 462 patients

were registered. Four hundred forty-eight of those patients (97.0

percent) satisfied the eligibility criteria. The control group

received mitomycin C intravenously on the day of and the day after

surgery, followed by oral 5-fluorouracil (5-FU) administration for

over six months. The PSK group received PSK orally for over three

years, in addition to mitomycin C and 5-FU as in the control group.

At the end of February 1990, the median follow-up time for this study

was four years (range, three to five years). The disease-free

survival curve and the survival curve of the PSK group were better

than those of the control group, and differences between the two

groups were statistically significant (disease-free survival, P =

0.013; survival, P = 0.013). These results indicate that adjuvant

immunochemotherapy with PSK was beneficial for curatively resected

colorectal cancer.

address:

Department of Surgery II

Tokai University

Kanagawa

Japan.

moonbeam

>

>

>

> > While at first glance your advice seems reasonable

> > enough I still found my self in disagreement after a

> > moment's thought.

> > The very fact that a person develops a malignancy is

> > evidence that their immune system has failed them. So

> > if by conventional therapy you are recommending

> > surgery with general anesthesia,

> > radiation and chemotherapy (especially those which are

> > derivatives of mustard gas), then you might want to

> > reconsider your position. All of the above options

> > can wreak havoc upon the immune system. Have you not

> > read the recent news releases which show that children

> > treated successfully for cancer with conventional

> > therapy have a much higher probability of developing

> > even more virulent cancers years later? The stories

> > suggested a causal relationship between the treatments

> > received initially and the new cancers which developed

> > later. Additionally, Judah Folkman, M.D., has offered

> > an explanation for the phenomenon of making a clean

> > surgical removal of a "primary or mother tumor" only

> > to be followed by an immediate metastatic explosion of

> > growth of tumors throughout the body resulting in

> > patient death in mere weeks. This is seen in as many

> > as l5% of surgically removed malignancies. If you

> > have this a same kind of tumor, destroying it by

> > radiation will trigger the same results. This

> > phenomenon has been replicated in recent animal

> > studies with

> > results published-----results which the gurus of

> > radiology have blatantly denied for many years. Have

> > you really watched the movie, "Cancer Warrior" the

> > link to which I posted here about 6-8 weeks ago? If

> > not, you would be wise to do so. I think we must

> > always bear in mind that the opinions and/or advice we

> > sometimes, so blithely, dispense in our posts here

> > ---can guide people to their deaths. Horrible,

> > certain deaths caused by treatments which can

> > literally cannibalize them physically--and

> > financially! Let us always remember, "First, do no

> > harm". It's your roll of the dice.

> >

> >

> >

> > __________________________________________________

> >